Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lab Corp and Atherotech Form Marketing Alliance

By HospiMedica staff writers
Posted on 18 Jul 2003
A marketing and distribution alliance relating to a new cholesterol test has been announced by Laboratory Corporation of America (LabCorp, Burlington, NC, USA) and Atherotech (Birmingham, AL, USA). More...


The agreement provides for the transfer of Atherotech's patented testing technology to LabCorp and, if certain conditions are met, LabCorp would then become the first clinical laboratory licensed to perform the assay for assessment of cardiovascular disease risk. The assay, called VAP (vertical auto profile), is an expanded cholesterol test designed to improve the identification of people at risk of heart disease by providing direct, detailed measurements of cholesterol subclasses that play important roles in the development of heart disease.

"We are pleased to offer the VAP Cholesterol Test as part of our broadly available menu of service offerings for cardiovascular disease,” said Myla Lai-Goldman, M.D., executive vice president, medical director, and chief scientific officer for LabCorp. "Many of our physician customers have been asking for this valuable test to help improve patient care.”

LabCorp is a leading US clinical laboratory, whose customers include doctors, hospitals, clinics, and other clinical laboratories. Atherotech is dedicated to improving the prevention, early diagnosis, and treatment of heart disease and other cardiovascular diseases.





Related Links:
LabCorp
Atherotech

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.